Riskpilot← Back to searchSign inGet full accessENDOTELIN AS
ASActiveOrg 883053052Kirkegata 48, 4006 StavangerOther human health activities n.e.c. · NACE 8699Est. 200111 employees
Revenue 2024
NOK 21,7M
+5% vs 2023
EBITDA margin
59.3%
+6% vs 2023
Equity ratio
49.9%
Financial strength
Net profit 2024
NOK 10,7M
+6% vs 2023
| Revenue | NOK 21,7M | +5% |
| EBITDA | NOK 12,8M | +6% |
| Net profit | NOK 10,7M | +6% |
| Total assets | NOK 29,8M | +8% |
| Equity | NOK 14,8M | +9% |
| Employees | 11 | — |
Legal name
ENDOTELIN AS
Org number
883053052
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
27. februar 2001
Share capital
NOK 100 000
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Tjenester innen helse, samt investeringer i fast eiendom og finansaktiva, og alt som herved er naturlig forbundet.
Address
Kirkegata 48, 4006 Stavanger
Phone
+4799291992
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 20 092 | 20 923 | 21 172 | 20 628 | 21 672 |
| Staff expenses | −3 678 | −3 751 | −4 310 | −4 964 | −4 915 |
| EBITDA | 12 767 | 13 436 | 12 993 | 12 118 | 12 843 |
| Depreciation & amort. | −239 | −272 | −303 | −326 | −326 |
| EBIT | 12 528 | 13 164 | 12 689 | 11 792 | 12 517 |
| Net financials | 994 | 1 013 | 1 064 | 1 120 | 1 211 |
| Profit before tax | 13 522 | 14 177 | 13 754 | 12 913 | 13 727 |
| Tax | 2 981 | 3 121 | 3 026 | 2 841 | 3 002 |
| Net profit | 10 541 | 11 056 | 10 728 | 10 072 | 10 725 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 071 | 26 624 | 27 884 | 27 474 | 29 775 |
| Equity | 10 239 | 11 295 | 12 403 | 13 592 | 14 845 |
| Long-term debt | 1 544 | 1 408 | 1 253 | 1 094 | 928 |
| Short-term debt | 13 288 | 13 921 | 14 228 | 12 788 | 14 002 |
| Total debt | 14 832 | 15 329 | 15 481 | 13 882 | 14 931 |
EBITDA margin
59.3%
This company
15.8%
Market median
+275% vs market
20202024
Equity ratio
49.9%
This company
38.2%
Market median
+31% vs market
20202024
Return on equity
72.2%
This company
18.4%
Market median
+292% vs market
20202024
Net profit margin
49.5%
This company
8.1%
Market median
+511% vs market
20202024
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
20202024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FF Deputy Member | Deputy Member | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2009 | |
| Deputy Chairman | 2009 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Finsnes Invest As
ENDOTELIN AS Board members of ENDOTELIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Finsnes | Deputy Member | 0 companies |
| Finn Finsnes | Chairman | 0 companies |
| Christine Lindeman Finsnes | Deputy Chairman | 0 companies |